Commentary on the risk of active tuberculosis

Archives of Pediatrics and Adolescent Medicine

Volumn 160, Issue 3, 2006, Pages 317-318

  Jereb, John A ^a   Nelson, Lisa J ^a   Castro, Kenneth G ^a  

^a Mail Stop E 10 ^*

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE;

BCG VACCINATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EDITORIAL; HONG KONG; HUMAN; IMMIGRANT; IMMIGRATION; INFECTION RISK; LONGITUDINAL STUDY; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; TUBERCULIN TEST; TUBERCULOSIS; TUBERCULOSIS CONTROL;

CHILD; EMIGRATION AND IMMIGRATION; FEMALE; HONG KONG; HUMANS; INCIDENCE; MALE; RISK FACTORS; TUBERCULIN; TUBERCULIN TEST; TUBERCULOSIS; UNITED STATES;

EID: 33644856856     PISSN: 10724710     EISSN: 10724710     Source Type: Journal    
DOI: 10.1001/archpedi.160.3.317     Document Type: Editorial

References (15)

1. Leung CC, Yew WW, Chang KC, et al. Risk of active tuberculosis among schoolchildren in Hong Kong. Arch Pediatr Adolesc Med. 2006;160:247-251.
2. Hesseling AC, Schaaf HS, Gie RP, Starke JR, Beyers N. A critical review of diagnostic approaches used in the diagnosis of childhood tuberculosis. Int J Tuberc Lung Dis. 2002;6:1038-1045.
3. Fine PE, Sterne JA, Ponninghaus JM, Rees RJ. Delayed-type hypersensitivity, mycobacterial vaccines and protective immunity. Lancet. 1994;344:1245-1249.
4. Nelson LJ, Schneider E, Wells CD, Moore M. Epidemiology of childhood tuberculosis in the United States, 1993-2001: the need for continued vigilance. Pediatrics. 2004;114:333-341.
5. Leung CC, Yew WW, Tam CM, et al. Tuberculin response in BCG vaccinated schoolchildren and the estimation of annual risk of infection in Hong Kong. Thorax. 2005;60:124-129.
6. Jereb J, Albalak R, Castro KG. The Arden House Conference on Tuberculosis, revisited: perspectives for tuberculosis elimination in the United States. Semin Respir Crit Care Med. 2004;25:255-269.
7. Daniel TM, Debanne SM. Estimation of the annual risk of tuberculosis infection for white men in the United States. J Infect Dis. 1997;175:1535-1537.
8. Alperstein G, Morgan KR, Mills K, Daniels L. Compliance with anti-tuberculosis preventive therapy among 6-year-old children. Aust N Z J Public Health. 1998;22:210-213.
9. Centers for Disease Control and Prevention. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Recomm Rep. 2000;49:1-51.
10. Centers for Disease Control and Prevention. Reported Tuberculosis in the United States, 2004. Atlanta, Ga: US Dept of Health and Human Services; 2005.
11. Institute of Medicine. Ending Neglect: The Elimination of Tuberculosis in the United States. Washington, DC: National Academy Press; 2000.
12. Schwartzman K, Oxlade O, Barr RG, et al. Domestic returns from investment in the control of tuberculosis in other countries. N Engl J Med. 2005;353:1008-1020.
13. Marais BJ, Gie RP, Schaaf HS, et al. The natural history of childhood intrathoracic tuberculosis: a critical review of literature from the pre-chemotherapy era. Int J Tuberc Lung Dis. 2004;8:392-402.
14. Pai M, Riley LW, Colford JM Jr. Interferon-γ assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis. 2004;4:761-776.
15. Mazurek GH, Jereb J, Lobue P, Iademarco MF, Metchock B, Vernon A. Division of Tuberculosis Elimination, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention (CDC). Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep. 2005;54:49-55.